Evommune

About:

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

Website: https://www.evommune.com

Top Investors: Andera Partners, RA Capital Management, B Capital, Marshall Wace, RTW Investments

Description:

Evommune is taking a tissue-based approach to insights and accelerating the development of transformative medicines for inflammatory diseases. Evommune creates novel strategies to treat inflammatory disorders by developing treatments that address symptoms while also halting disease progression. Evommune's pipeline contains initiatives aimed at combating highly prevalent inflammatory illnesses. Its mission is to drive real advancements for patients suffering from these diseases, with all of its programs designed to produce best-in-class profiles.